Treatment of advanced hepatocellular carcinoma: beyond sorafenib

被引：18
|
作者：
Meyer, Tim [1 ]
机构：
[1] UCL, UCL Canc Inst, London WC1E 6BT, England
来源：
LANCET GASTROENTEROLOGY & HEPATOLOGY | 2018年 / 3卷 / 04期
关键词：
DOUBLE-BLIND; PHASE-3; TRIAL;
D O I：
10.1016/S2468-1253(17)30255-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：218 / 220
页数：4
相关论文
共 50 条
  • [31] Sorafenib in Advanced Hepatocellular Carcinoma Reply
    Llovet, Josep M.
    Bruix, Jordi
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (23): : 2498 - 2499
  • [32] Oral sorafenib for advanced hepatocellular carcinoma
    Nature Clinical Practice Oncology, 2006, 3 (12): : 648 - 649
  • [33] Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma
    Sanoff, Hanna K.
    Chang, YunKyung
    Lund, Jennifer L.
    O'Neil, Bert H.
    Dusetzina, Stacie B.
    ONCOLOGIST, 2016, 21 (09): : 1113 - 1120
  • [34] Sorafenib for the treatment of hepatocellular carcinoma
    Woerns, Marcus Alexander
    Galle, Peter Robert
    HEPATIC ONCOLOGY, 2014, 1 (02) : 189 - 204
  • [35] Systemic therapy for hepatocellular carcinoma: beyond sorafenib
    Boland, Patrick
    Wu, Jennifer
    CHINESE CLINICAL ONCOLOGY, 2018, 7 (05)
  • [36] S-1 plus sorafenib for the treatment of advanced hepatocellular carcinoma
    Huang, Wukui
    You, Lina
    Liu, Dengyao
    Yang, Shufa
    Liu, Mo
    Wang, Hailin
    Wang, Pingju
    Baikere, Pahaerding
    Gu, Peng
    Abulikemu, Abulajiang
    Yuan, Shaoha
    Fan, Xiwen
    JOURNAL OF BUON, 2016, 21 (06): : 1388 - 1393
  • [37] Expression of Keratin 19 in advanced hepatocellular carcinoma and resistance to sorafenib treatment
    Wen, X.
    Xu, X.
    TRANSPLANTATION, 2019, 103 (08) : 62 - 62
  • [38] SORAFENIB TREATMENT FOR HEPATOCELLULAR CARCINOMA (HCC) IN PATIENTS WITH ADVANCED LIVER DISEASE
    Alves, Rogerio C.
    Alves, Daniele E.
    Guz, Betty
    Viana, Monica V.
    Harriz, Michelle C.
    Matos, Carla A.
    Terrabuio, Deborah
    Chagas, Aline
    Moutinho, Renata D.
    Taddeo, Eliane F.
    Duarte, Kelly C.
    Oliveira, George P.
    Ribeirol, Juliana M.
    Kondo, Mario
    Gampel, Otavio
    Poletti, Paula
    HEPATOLOGY, 2010, 52 (04) : 1193A - 1193A
  • [39] Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma
    Takada, Hitomi
    Kurosaki, Masayuki
    Nakanishi, Hiroyuki
    Takahashi, Yuka
    Itakura, Jun
    Tsuchiya, Kaoru
    Yasui, Yutaka
    Tamaki, Nobuharu
    Takaura, Kenta
    Komiyama, Yasuyuki
    Higuchi, Mayu
    Kubota, Youhei
    Wang, Wann
    Okada, Mao
    Enomoto, Nobuyuki
    Izumi, Namiki
    PLOS ONE, 2018, 13 (06):
  • [40] Cost-effectiveness of Sorafenib for Treatment of Advanced Hepatocellular Carcinoma in India
    Gupta, Nidhi
    Verma, Rohan K.
    Prinja, Shankar
    Dhiman, Radha K.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2019, 9 (04) : 468 - 475
12345